Sangamo Therapeutics Announces Q1 2024 Financial Results and ...

Sangamo Therapeutics Reports Recent Business Highlights and ...

Revenues for the first quarter ended March 31, 2024 were $0.5 million , compared to $158.0 million for the same period in 2023. The decrease of ...

Sangamo Therapeutics Announces First Quarter 2024 Conference ...

(Nasdaq: SGMO), a genomic medicine company, announced today that the company has scheduled the release of its first quarter 2024 financial ...

Sangamo Therapeutics Reports Q1 2024 Results: A Deep Dive into ...

First Quarter Financial Performance. The first quarter of 2024 was challenging for Sangamo, with a reported consolidated net loss of $49.1 ...

Sangamo Therapeutics Announces Q1 2024 Financial Results and ...

Sangamo also announced the discovery of their next-generation Modular Integrase (MINT) platform, a method designed for large-scale genome ...

Sangamo Therapeutics Reports Recent Business Highlights and ...

(Nasdaq: SGMO), a genomic medicines company, today reported business highlights and first quarter 2024 financial results. “Sangamo continues to ...

Sangamo Therapeutics Reports Recent Business Highlights and ...

Sangamo Therapeutics Reports Recent Business Highlights and First Quarter 2024 Financial Results ... By clicking “Accept All Cookies”, you agree to the storing of ...

Sangamo Therapeutics Reports Recent Business Highlights and ...

RICHMOND, Calif., May 09, 2024--SANGAMO THERAPEUTICS REPORTS RECENT BUSINESS HIGHLIGHTS AND FIRST QUARTER 2024 FINANCIAL RESULTS.

Sangamo Therapeutics Reports Recent Business Highlights and ...

Consolidated net income available for common stockholders for the third quarter ended September 30, 2024 was $10.7 million, or $0.04 per share ...

News Releases | Investor Relations - Sangamo Therapeutics, Inc.

(Nasdaq: SGMO), a genomic medicine company, announced today that the company has scheduled the release of its third quarter 2024 financial results after the ...

Sangamo Therapeutics Reports Recent Business Highlights and ...

Sangamo Therapeutics Reports Recent Business Highlights and Second Quarter 2024 Financial Results ; Interest and other income, net. 1,030 ; Loss ...

Sangamo Therapeutics, Inc.: Overview

(Nasdaq: SGMO), a genomic medicine company, announced today that the company has scheduled the release of its third quarter 2024 financial results after the ...

Voyager Therapeutics Reports First Quarter 2024 Financial and ...

We expect to achieve IND filings for all three of these gene therapy programs in 2025. We maintain a strong cash position of approximately $400 million at ...

Sangamo Therapeutics Announces Q2 2024 Results and Business ...

For the second quarter ending June 30, 2024, Sangamo reported a consolidated net loss of $36.1 million, or $0.18 per share, compared to a net ...

HLS Therapeutics Announces Q3 2024 Financial Results

Excluding cost of product sales, operational expenses for the three and nine months ended September 30, 2024, decreased 15% and 10%, ...

SGMO - Sangamo Therapeutics, Inc. Latest Stock News & Market ...

Sangamo Therapeutics, Inc. (Nasdaq: SGMO) has announced the release of its first quarter 2024 financial results on Thursday, May 9, 2024. The company will hold ...

SGMO - Sangamo Therapeutics Inc Stock Price and Quote

Sangamo: Q1 Earnings Snapshot. (Associated Press Finance). 04:01PM · Sangamo Therapeutics Reports Recent Business Highlights and First Quarter 2024 Financial ...

Sangamo Therapeutics, Inc. (SGMO) Stock Price, Quote & News

RICHMOND, Calif.--(BUSINESS WIRE)--SANGAMO THERAPEUTICS REPORTS RECENT BUSINESS HIGHLIGHTS AND FIRST QUARTER 2024 FINANCIAL RESULTS. 6 months ago - Business ...

News Releases | Investor Relations | Sangamo Therapeutics, Inc.

BRISBANE, Calif. --(BUSINESS WIRE)--Jul. 29, 2021-- Sangamo Therapeutics, Inc. (Nasdaq: SGMO), a genomic medicine company, announced today that the ...

Sangamo Therapeutics (SGMO) Stock Latest News - Finance Charts

RICHMOND, Calif.--(BUSINESS WIRE)--SANGAMO THERAPEUTICS ANNOUNCES PRICING OF $24.0 MILLION REGISTERED DIRECT OFFERING. Sangamo Therapeutics Reports Recent ...

Sangamo Therapeutics, Inc. on LinkedIn: Our Q2 financial results ...

Our Q2 financial results will be announced on Tuesday, August 6, 2024, with a conference call at 4:30 PM ET ... Our 2024 Q1 financial results ...